Wellness & Workforce Solution for Lupus/Lupus Nephritis

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Lupus Nephritis
Interventions
BEHAVIORAL

Micro-learning content

This is a series of modules designed to provide disease education, additional communication through 'push notifications,' promote self-management, and medication adherence in women of color with lupus and lupus nephritis. Leveraging technology, this program is asynchronous, promotes engagement and retention of information through micro-learning, and allows the investigators to better understand patient experiences beyond structured surveys by capturing what is happening in the patient-coach relationship.

BEHAVIORAL

Health360x app

The coach and participant will use problem-solving tools embedded in Health360x to map out potential barriers to goal attainment and create goal action plans. This application has the potential to help improve health-related quality of life, and reduce morbidity and mortality associated with Lupus. The intervention also tests the role of health coaches in the lupus ecosystem. The potential economic gain and impact on more extant social determinants of health can create long ranging benefits on the health and wellbeing of the community.

BEHAVIORAL

Culturally congruent coaching

The coaching process includes specified visits over the course of our proposed 6-month intervention. These visits will occur remotely using HIPAA compliant video conferencing tools or in person when it is safe and convenient to meet in person. Overall, the coaches will work with Lupus patients to facilitate experiential learning, improve functioning and performance in the context of working towards specific goals.

All Listed Sponsors
collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

Morehouse School of Medicine

OTHER

NCT06217107 - Wellness & Workforce Solution for Lupus/Lupus Nephritis | Biotech Hunter | Biotech Hunter